David E. I. Pyott, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 7,440 shares at $299.00 ($2.2M) on 2025-03-24, disclosed to the SEC on 2025-03-25.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BMRN | BUY | 2020-09-01 | $1.0M | — | Filing → |
| AVY | SELL | 2020-02-05 | $1.3M | — | Filing → |
| AVY | SELL | 2018-11-28 | $186K | — | Filing → |